chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19, FLUX, RSV
Symptoms: Conjunctivitis, Influenza virus test, Respiratory syncytial virus test, SARS-CoV-2 test
Clinical narrative: pink eye; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation; rsv vaccine prot.subunit pref 2v (RSV VACCINE PROT.SUBUNIT PREF 2V), as dose number unknown, single (Batch/Lot number: unknown) for immunisation; for immunisation; influenza vaccine (INFLUENZA VACCINE), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: CONJUNCTIVITIS (non-serious), outcome "unknown", described as "pink eye". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient mentioned that she went into a walk-in clinic last Saturday (as reported) and they tested her for COVID, RSV, and the flu but never heard from them. She further said that she got all of her COVID, RSV, and flu vaccines and the patient says she had a pink eye.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: I received all my covid vaccines and once I received a shingles vaccine in the same covid arm. It has not worked; I received all my covid vaccines and once I received a shingles vaccine in the same covid arm. It has not worked; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown), in arm for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: VARICELLA ZOSTER VACCINE taken for immunisation. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "I received all my covid vaccines and once I received a shingles vaccine in the same covid arm. It has not worked". Additional information: patient reported issues with vaccines. Patient received all covid vaccines and once patient received a shingles vaccine in the same covid arm. It has not worked.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Squamous cell carcinoma of lung
Clinical narrative: Lung cancer/developed lung cancer. She was completely non symptomatic prior to her diagnosis of squamous cell; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for COVID-19 immunisation; Bnt162b2 (DOSE 2, SINGLE), for COVID-19 immunisation; Bnt162b2 omi ba.4-5 (DOSE 3 (BOOSTER), SINGLE), for COVID-19 immunisation; Bnt162b2 omi ba.4-5 (DOSE 4 (BOOSTER), SINGLE), for COVID-19 immunisation. The following information was reported: SQUAMOUS CELL CARCINOMA OF LUNG (medically significant), outcome "unknown", described as "Lung cancer/developed lung cancer. She was completely non symptomatic prior to her diagnosis of squamous cell". Clinical Course: Reporters wife took the 5 booster for Covid. Right after she developed lung cancer. She was completely non symptomatic prior to her diagnosis of squamous cell. Please have someone contact me with a phone number to call."  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Sex: M
Vaccine: COVID19
Symptoms: Drug ineffective, Suspected COVID-19
Clinical narrative: Both my wife and I came down with COVID over holiday this year for the first time; Both my wife and I came down with COVID over holiday this year for the first time; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A male patient in his 60's received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset Nov2023, outcome "unknown" and all described as "Both my wife and I came down with COVID over holiday this year for the first time". Clinical course: Both wife and patient came down with COVID over holiday this year for the first time. The advances in both vaccines and treatments turned what two years ago had killed many of our generation, into just a bad cold. Many thanks to the scientists and staff at all the pharmaceutical companies involved and also to the agencies who made availability of the treatments to all. As a former employee in the mid 60s it makes patient proud of the association he had with company.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300434836 same reporter/product/event, different dose;
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: got Covid-19; got Covid-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "got Covid-19". Therapeutic measures were taken as a result of drug ineffective, covid-19 which included Paxlovid. Clinical course: The reporter reported that she had previously received multiple doses of the Pfizer Covid-19 vaccine and got Covid-19 several weeks ago.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: U
Vaccine: COVID19
Symptoms: Brain neoplasm
Clinical narrative: brain tumor; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in 2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose 1, Single), for COVID-19 immunization; Bnt162b2 (Dose 2, Single), for COVID-19 immunization. The following information was reported: BRAIN NEOPLASM (medically significant) with onset 2023, outcome "unknown", described as "brain tumor".  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Death
Clinical narrative: girlfriends mom died because of the vaccine; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID.  A female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEATH (death), outcome "fatal", described as "girlfriends mom died because of the vaccine". The date and cause of death for the patient were unknown. It was not reported if an autopsy was performed. Clinical course: Caller calling because Pfizer distributed the covid vaccines without testing the effectives of it first and her girlfriends mom died because of the vaccine. Caller is angry that he was asking for a simple question and he cant get the answer Created Manual adverse event (AE) form caller said that her girlfriend's mom died because of the vaccine also he and her girlfriend got experience adverse effect because of the covid vaccine  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Reported Cause(s) of Death: girlfriends mom died because of the vaccine
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation
Clinical narrative: she have an AFIB; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ATRIAL FIBRILLATION (medically significant), outcome "unknown", described as "she have an AFIB".  Clinical course: The caller mentioned that she got the Pfizer COVID shot and was supposed to have the Pfizer RSV shot Abrysvo. She said she did not know what it is because she had an AFIB and the person she spoke to didn't ask her anything when the appointment was made. She added that she got little nervous because she did not know what it was and didn't take it but she wanted to know if that could be taken. She mentioned she got the Pfizer COVID vaccine and she had AFIB or heart problems.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Mass, Peripheral swelling
Clinical narrative: the reverse reactions that cause the arm to swell as it gets hot and hard; the reverse reactions that cause the arm to swell as it gets hot and hard; the reverse reactions that cause the arm to swell as it gets hot and hard; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A female patient received bnt162b2 omi xbb.1.5 (BNT162B2 OMI XBB.1.5), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1 , Unknown manufacturer), for COVID-19 immunization; Covid-19 vaccine (Dose 2, Unknown manufacturer), for COVID-19 immunization. The following information was reported: PERIPHERAL SWELLING (non-serious), MASS (non-serious), FEELING HOT (non-serious), outcome "unknown" and all described as "the reverse reactions that cause the arm to swell as it gets hot and hard".  Additional information : Caller will be getting her fourth vaccine but needs to get it in the hip not in the arm because of the reverse reactions that cause the arm to swell as it gets hot and hard. But if it is injected in the hip, it was fine. Created Manual AE because the caller mentioned that she is having a reverse reactions that cause her arm to swell as it gets hot and hard due to the vaccination. Also, this was already her fourth vaccine so she wanted to make sure if she can get injected by her hip because it has no adverse reaction.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Dementia
Clinical narrative: dementia; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID.  A male patient received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DEMENTIA (medically significant), outcome "unknown".  Clinical course: Caller said her husband has dementia and he is currently in a care home. Caller said the care home needs proof that he has had his three COVID-19 shots but the card he was given got lost. Caller said all his shots were from Pfizer and she was looking for a way to get a copy of all three of her husband's shots because they were not given in the same place.   The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300439330 same patient/event, different vaccine dose;US-PFIZER INC-202300439331 same patient/event, different vaccine dose;
Sex: U
Vaccine: COVID19
Symptoms: Wound
Clinical narrative: developing open wounds on my body that will not heal; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient.  A patient (no qualifiers provided) received bnt162b2 (BNT162B2), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: WOUND (medically significant), outcome "not recovered", described as "developing open wounds on my body that will not heal". The event "developing open wounds on my body that will not heal" required physician office visit.  Clinical information: Ever since I received the first 3 COVID shots. I am developing open wounds on my body that will not heal. I have been to several doctors including a dermatologist and have never seen something like this. I want a detailed explanation. I am in the medical field.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300439449 same patient/event, different vaccine dose;US-PFIZER INC-202300439450 same patient/event, different vaccine dose;
Age: 57.0
Sex: F
Vaccine: COVID19, FLUX
Symptoms: Oral herpes
Clinical narrative: cold sore in her mouth; Initial information received on 20-Nov-2023 regarding an unsolicited valid non-serious case received from a consumer/non-hcp.  This case involves a 57 years old female patient who experienced cold sore in her mouth after receiving influenza vaccine and COVID-19 vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 17-Nov-2023, the patient received an unknown dose of suspect influenza vaccine and COVID-19 vaccine both of which are produced by unknown manufacturer (formulation; strength; expiry date; lot number not reported) via unknown route in unknown administration site for prophylactic vaccination. Information regarding batch number will be requested in this case.  On 18-Nov-2023 the patient developed cold sore in her mouth (oral herpes) (latency: 1 day).  It was reported, "The patient doesn't think dupixent is making a difference", as her symptoms of scaly skin and cracking skin, are ongoing and are unchanged since start of therapy. patient stated she is unsure if she will continue on the medication."   Action taken was not applicable.  The patient was treated with hydrogen peroxide for Oral herpes.  At time of reporting, the outcome was Recovering / Resolving for the event.
Sex: U
Vaccine: FLU4
Symptoms: No adverse event, Occupational exposure to product
Clinical narrative: dose spilled onto the nurse's hands with no reported adverse event; Initial information received on 11-Oct-2023  regarding an unsolicited valid non-serious case received from other health professional.  This case involves an unknown age and gender patient for whom influenza quadrival A-B high dose HV vaccine [Fluzone High-Dose Quadrivalent] dose spilled onto the hands with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient was exposed to 1 unit dose of suspect influenza quadrival A-B high dose HV vaccine, injection (strength, route: unknown) (Batch number: U8130DA; expiry date: 30-Jun-2024) (indication: immunization) as the dose spilled onto the hands with no reported adverse event (accidental exposure to product) (unknown latency).  Reportedly, nurse was about to give a patient Fluzone High-Dose Quadrivalent and noticed that the plunger of the vaccine was crooked like it was tilted to the right. When the nurse tried to pull out the plunger, the medication spilled on to the nurse's hands.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 76.0
Sex: M
Vaccine: FLUA4
Symptoms: Product administered at inappropriate site, Vaccination site haemorrhage
Clinical narrative: When it was administered he bled some; Vaccine was given to low, possibly subcutaneously; This spontaneous case was received on 28-Nov-2023 from pharmacist via Communications (reference number: SEQW23-04538) and concerned a 76-year-old, male patient.  The patient's medical history was not reported. The patient's concomitant medications included finasteride, atenolol, valsartan, doxazosin and amlodipine, all for unreported indication.  On 08-Nov-2023, the patient was vaccinated with Fluad Quadrivalent (influenza vaccine inact sag 4v; dose: 0.5 ml, route of administration: possibly subcutaneous and anatomical location: not reported) as influenza immunization for patients over 65 years of age and older. It was reported that the patient thought that the vaccine was given too low, possibly subcutaneously (explicitly coded as 'Inappropriate route of vaccination'). The batch number reported was 371640, and expiration date 30-Jun-2024.  On the same day,  when the vaccine was administered patient bled some. As it was reported, there was no pain, and the patient was just worried if the dose was not valid.  At the time of reporting, the event 'vaccination site hemorrhage' outcome was not reported.  The reporter did not provide a causality assessment.  The case was assessed as non-serious.  Company comment: A 76-year-old patient received the suspect Fluad Quadrivalent vaccine too low, possibly subcutaneously (explicitly coded as 'Inappropriate route of vaccination'). On the same day following vaccination, the patient experienced vaccination site haemorrhage. Incorrect route of product administration is assessed as not related per company's conventions. Causality is assessed as possible for event vaccination site haemorrhage, due to suggestive temporal relationship and anatomical plausibility.; Sender's Comments: A 76-year-old patient received the suspect Fluad Quadrivalent vaccine too low, possibly subcutaneously (explicitly coded as 'Inappropriate route of vaccination'). On the same day following vaccination, the patient experienced vaccination site haemorrhage. Incorrect route of product administration is assessed as not related per company's conventions. Causality is assessed as possible for event vaccination site haemorrhage, due to suggestive temporal relationship and anatomical plausibility.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site induration, Injection site pruritus, Rash macular
Clinical narrative: I got vaccinated late in the afternoon. By the time I was in the shower the next morning at 6 am, I pulled off the bandaid and  saw a large red blotch on my arm. It got a little bigger and started to itch as the day progressed. The area is firm and almost hard with only slight soreness. It is much like the blotch I got the first time I got vaccinated for covid with moderna's product. This time it was the non-mrna novavax 2023 product. "Covid arm" was reportedly most often reported with moderna, but it appears to be happening to me with novavax. And it's a pretty quick onset, not days later. I got my first covid vaccine in my left arm. This time was also in my left arm in case that matters.
Age: 60.0
Sex: F
Vaccine: COVID19, FLUR4, COVID19, FLU4, RSV
Symptoms: Injection site pain, Pain, Sleep disorder
Clinical narrative: AREA AROUND THE SHOT ON RIGHT ARM IS PAINFUL, STARTING SHORTLY AFTER GETTING SHOTS. WAKES UP AT NIGHT DUE TO PAIN WHEN UNCONSCIOUSLY MOVED ARM. NOT SWELLING OR REDNESS THAT PATIENT NOTICED.
Age: 60.0
Sex: F
Vaccine: COVID19, FLUR4, COVID19, FLU4, RSV
Symptoms: Loss of personal independence in daily activities, Mobility decreased, Pain, Pain in extremity, Sleep disorder
Clinical narrative: AREA AROUND THE SHOT ON RIGHT ARM IS PAINFUL, STARTING SHORTLY AFTER GETTING SHOTS. WAKES UP AT NIGHT DUE TO PAIN WHEN UNCONSCIOUSLY MOVED ARM. NOT SWELLING OR REDNESS THAT PATIENT NOTICED.
Age: 60.0
Sex: F
Vaccine: COVID19, FLUR4, COVID19, FLU4, RSV
Symptoms: Tenderness
Clinical narrative: AREA AROUND THE SHOT ON RIGHT ARM IS PAINFUL, STARTING SHORTLY AFTER GETTING SHOTS. WAKES UP AT NIGHT DUE TO PAIN WHEN UNCONSCIOUSLY MOVED ARM. NOT SWELLING OR REDNESS THAT PATIENT NOTICED.
Age: 47.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Blood glucose increased, Cardiac stress test, Chest discomfort, Drug screen negative, Electrocardiogram ST segment elevation
Clinical narrative: Several hours after receiving the injection, I started to feel slightly ill. I noticed swelling on my left arm at the side of the injection, and I began to feel slightly warm.  Sleep that night was  somewhat uneasy.  The next day, perhaps due to lifestyle circumstances, I felt quite stressed, so in the early evening I went for a short bike ride, which I do multiple times per week on a regular basis. When I came home from the ride and had been sitting on the sofa for around 45 minutes, my Watch alerted me to the fact that my resting heart rate was 125 bpm.  I had eaten normally drinking normally during the day, with 15 ounce glass of wine and no recreational drug use.  I felt my breathing was somewhat irregular and felt some pressure under my chest.  I drove myself to the emergency room, emergency center, where I had a close to normal blood pressure, but had tachycardia.   CBC, and complete metabolic panel were taken along with a urinary drug screen, which came back negative .   in the bloodwork glucose was slightly elevated along with white blood cells and neutrophils.   Troponin was zero.   an EKG was administered, and the findings were tachycardia with ST elevation.   A previous EKG in January 2023, along with anA previous EKG in January 2023, along with a stress, echo test had revealed no abnormalities prior to this incident.  I have never been treated for tachycardia in my whole life.   After being observed in the hospital bed for about an hour and a half my heart rate begin to normalize.   I was discharged when it reached the upper 80s and my blood pressure was normal, once all the tests had come back with relatively benign results.   My normal resting heart rate is around 65 to 70.   When I returned home at around 10:30 in the evening, I took a nap and tablet, then fell asleep, for some fitful sleep.   It was not until the next day that my resting heart rate return to normal.  I have been feeling normal since.
Age: 47.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Electrocardiogram abnormal, Feeling hot, Full blood count normal, Irregular breathing, Malaise
Clinical narrative: Several hours after receiving the injection, I started to feel slightly ill. I noticed swelling on my left arm at the side of the injection, and I began to feel slightly warm.  Sleep that night was  somewhat uneasy.  The next day, perhaps due to lifestyle circumstances, I felt quite stressed, so in the early evening I went for a short bike ride, which I do multiple times per week on a regular basis. When I came home from the ride and had been sitting on the sofa for around 45 minutes, my Watch alerted me to the fact that my resting heart rate was 125 bpm.  I had eaten normally drinking normally during the day, with 15 ounce glass of wine and no recreational drug use.  I felt my breathing was somewhat irregular and felt some pressure under my chest.  I drove myself to the emergency room, emergency center, where I had a close to normal blood pressure, but had tachycardia.   CBC, and complete metabolic panel were taken along with a urinary drug screen, which came back negative .   in the bloodwork glucose was slightly elevated along with white blood cells and neutrophils.   Troponin was zero.   an EKG was administered, and the findings were tachycardia with ST elevation.   A previous EKG in January 2023, along with anA previous EKG in January 2023, along with a stress, echo test had revealed no abnormalities prior to this incident.  I have never been treated for tachycardia in my whole life.   After being observed in the hospital bed for about an hour and a half my heart rate begin to normalize.   I was discharged when it reached the upper 80s and my blood pressure was normal, once all the tests had come back with relatively benign results.   My normal resting heart rate is around 65 to 70.   When I returned home at around 10:30 in the evening, I took a nap and tablet, then fell asleep, for some fitful sleep.   It was not until the next day that my resting heart rate return to normal.  I have been feeling normal since.
Age: 47.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Metabolic function test, Neutrophil count increased, Peripheral swelling, Sleep disorder, Stress
Clinical narrative: Several hours after receiving the injection, I started to feel slightly ill. I noticed swelling on my left arm at the side of the injection, and I began to feel slightly warm.  Sleep that night was  somewhat uneasy.  The next day, perhaps due to lifestyle circumstances, I felt quite stressed, so in the early evening I went for a short bike ride, which I do multiple times per week on a regular basis. When I came home from the ride and had been sitting on the sofa for around 45 minutes, my Watch alerted me to the fact that my resting heart rate was 125 bpm.  I had eaten normally drinking normally during the day, with 15 ounce glass of wine and no recreational drug use.  I felt my breathing was somewhat irregular and felt some pressure under my chest.  I drove myself to the emergency room, emergency center, where I had a close to normal blood pressure, but had tachycardia.   CBC, and complete metabolic panel were taken along with a urinary drug screen, which came back negative .   in the bloodwork glucose was slightly elevated along with white blood cells and neutrophils.   Troponin was zero.   an EKG was administered, and the findings were tachycardia with ST elevation.   A previous EKG in January 2023, along with anA previous EKG in January 2023, along with a stress, echo test had revealed no abnormalities prior to this incident.  I have never been treated for tachycardia in my whole life.   After being observed in the hospital bed for about an hour and a half my heart rate begin to normalize.   I was discharged when it reached the upper 80s and my blood pressure was normal, once all the tests had come back with relatively benign results.   My normal resting heart rate is around 65 to 70.   When I returned home at around 10:30 in the evening, I took a nap and tablet, then fell asleep, for some fitful sleep.   It was not until the next day that my resting heart rate return to normal.  I have been feeling normal since.
Age: 47.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Tachycardia, Troponin normal, White blood cell count increased
Clinical narrative: Several hours after receiving the injection, I started to feel slightly ill. I noticed swelling on my left arm at the side of the injection, and I began to feel slightly warm.  Sleep that night was  somewhat uneasy.  The next day, perhaps due to lifestyle circumstances, I felt quite stressed, so in the early evening I went for a short bike ride, which I do multiple times per week on a regular basis. When I came home from the ride and had been sitting on the sofa for around 45 minutes, my Watch alerted me to the fact that my resting heart rate was 125 bpm.  I had eaten normally drinking normally during the day, with 15 ounce glass of wine and no recreational drug use.  I felt my breathing was somewhat irregular and felt some pressure under my chest.  I drove myself to the emergency room, emergency center, where I had a close to normal blood pressure, but had tachycardia.   CBC, and complete metabolic panel were taken along with a urinary drug screen, which came back negative .   in the bloodwork glucose was slightly elevated along with white blood cells and neutrophils.   Troponin was zero.   an EKG was administered, and the findings were tachycardia with ST elevation.   A previous EKG in January 2023, along with anA previous EKG in January 2023, along with a stress, echo test had revealed no abnormalities prior to this incident.  I have never been treated for tachycardia in my whole life.   After being observed in the hospital bed for about an hour and a half my heart rate begin to normalize.   I was discharged when it reached the upper 80s and my blood pressure was normal, once all the tests had come back with relatively benign results.   My normal resting heart rate is around 65 to 70.   When I returned home at around 10:30 in the evening, I took a nap and tablet, then fell asleep, for some fitful sleep.   It was not until the next day that my resting heart rate return to normal.  I have been feeling normal since.
Age: 44.0
Sex: F
Vaccine: FLU4
Symptoms: Petechiae, Rash
Clinical narrative: Petichiae like rash on legs especially upper thigh. Still there as of 12/8/23. No pain or other symptoms.
Age: 37.0
Sex: F
Vaccine: PPV
Symptoms: Blister, Chills, Decreased appetite, Erythema, Malaise
Clinical narrative: Fever above 102, swelling, chills, lack of appetite, redness, blister, malaise
Age: 37.0
Sex: F
Vaccine: PPV
Symptoms: Pyrexia, Swelling
Clinical narrative: Fever above 102, swelling, chills, lack of appetite, redness, blister, malaise
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site discolouration, Injection site dryness, Injection site erythema
Clinical narrative: Redness at site of injection, size of nickel to quarter. Redness resolved but dry, discolored skin at the injection site has persisted since injection to current date 12/9/2023. No pain at injection site or treatment required.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia, Pain in extremity
Clinical narrative: Patient has reported pain that begins in the deltoid region that extends down his arm into his hand between his thumb and index finger
Age: 27.0
Sex: F
Vaccine: FLUC4
Symptoms: Urticaria
Clinical narrative: Hives
Age: 75.0
Sex: M
Vaccine: RSV
Symptoms: Cough, Productive cough, Pulmonary congestion, Respiratory tract congestion, SARS-CoV-2 test negative
Clinical narrative: 30 minute coughing spells, extracting Flem, Congestion, after 4 days, I called the Clinic; they checked me out and determined what meds to give me see below.
Age: 75.0
Sex: M
Vaccine: RSV
Symptoms: Sputum discoloured
Clinical narrative: 30 minute coughing spells, extracting Flem, Congestion, after 4 days, I called the Clinic; they checked me out and determined what meds to give me see below.
Age: 77.0
Sex: F
Vaccine: UNK
Symptoms: Ascending flaccid paralysis, CSF protein increased, Endotracheal intubation, Guillain-Barre syndrome
Clinical narrative: Patient reported getting a Flu (3-4 weeks ago) and Covid (2 weeks ago) vaccination.  At the time of presentation she had developed ascending flaccid paralysis.  She underwent LP at outside hospital which revealed albuminocytologic dissociation consistent with Guillain-Barre Syndrome.  She was intubated 12/8 for airway protection.
Age: 82.0
Sex: F
Vaccine: RSV
Symptoms: Injection site reaction, Rash, Rash erythematous, Rash pruritic
Clinical narrative: Patient described developing itchy/red/painful rash, about 4inches x 4inches in size above elbow in arm which she received vaccine. Rash developed 12/07/2023 according to patient. She has been using topical Benadryl cream (diphenhydramine) and topical hydrocortisone cream. She says this has helped reduce pain and redness of rash, and is slowly diminishing size of rash.
Age: 71.0
Sex: F
Vaccine: RSV
Symptoms: Chills, Heart rate irregular, Hyperhidrosis
Clinical narrative: severe chills, severe sweating and irregular heart beats
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia, Tremor
Clinical narrative: Chills with shaking followed by 100.5 fever for 8 hours
Age: 42.0
Sex: M
Vaccine: FLU4
Symptoms: Arthralgia, Fatigue, Muscular weakness, Musculoskeletal stiffness, Myalgia
Clinical narrative: On day 2 I experienced stiffness in my neck and was fatigued.  On day 3 my shoulder began to hurt in the muscle and joint and I had weakness in the arm.  The neck stiffness was gone by day 4 but the arm and shoulder issues lasted nearly a month.
Age: 32.0
Sex: F
Vaccine: RSV
Symptoms: Caesarean section, Complication of pregnancy, Culture negative, Dizziness, Exposure during pregnancy
Clinical narrative: 32yo G1P0 with EDD 12/20/23 by LMP consistent with 6w5d u/s.  Pregnancy was complicated by history of infertility due to endometriosis with spontaneous conception, anxiety (no meds), marginal cord insertion.  For marginal cord insertion, she had been followed with growth scans as recently as 11/27/23 which showed  appropriate interval growth (AC 48%ile, EFW 2711g in 25th %ile) and had BPP 8/8 at that time. She had  negative genetics screening by Prequel (neg trisomy 13/18/21, microdeletions, expanded aneuploidies), and was GBS+ without concern for PPROM. She had minor symptoms as described in earlier portion of this report soon after the vaccine and an office visit with normal vitals/exam and fetal heart tones less than 24h prior to noting sudden decrease in fetal movement.  She received the RSV vaccine at 36wk 6d and had stillbirth/IUFD at 37wk 5-6d.   The adverse event was stillbirth/IUFD. Unknown if this was related to vaccine but due to no other understood explanation or probable cause for this significant event and the stillbirth occurred within 1wk of administering vaccine,  reporting for potential investigation if pattern were to emerge.
Age: 32.0
Sex: F
Vaccine: RSV
Symptoms: Feeling abnormal, Feeling hot, Foetal death, Foetal heart rate decreased, Foetal hypokinesia
Clinical narrative: 32yo G1P0 with EDD 12/20/23 by LMP consistent with 6w5d u/s.  Pregnancy was complicated by history of infertility due to endometriosis with spontaneous conception, anxiety (no meds), marginal cord insertion.  For marginal cord insertion, she had been followed with growth scans as recently as 11/27/23 which showed  appropriate interval growth (AC 48%ile, EFW 2711g in 25th %ile) and had BPP 8/8 at that time. She had  negative genetics screening by Prequel (neg trisomy 13/18/21, microdeletions, expanded aneuploidies), and was GBS+ without concern for PPROM. She had minor symptoms as described in earlier portion of this report soon after the vaccine and an office visit with normal vitals/exam and fetal heart tones less than 24h prior to noting sudden decrease in fetal movement.  She received the RSV vaccine at 36wk 6d and had stillbirth/IUFD at 37wk 5-6d.   The adverse event was stillbirth/IUFD. Unknown if this was related to vaccine but due to no other understood explanation or probable cause for this significant event and the stillbirth occurred within 1wk of administering vaccine,  reporting for potential investigation if pattern were to emerge.
Age: 32.0
Sex: F
Vaccine: RSV
Symptoms: Headache, Laboratory test, Nasal congestion, Nausea, Pathology test
Clinical narrative: 32yo G1P0 with EDD 12/20/23 by LMP consistent with 6w5d u/s.  Pregnancy was complicated by history of infertility due to endometriosis with spontaneous conception, anxiety (no meds), marginal cord insertion.  For marginal cord insertion, she had been followed with growth scans as recently as 11/27/23 which showed  appropriate interval growth (AC 48%ile, EFW 2711g in 25th %ile) and had BPP 8/8 at that time. She had  negative genetics screening by Prequel (neg trisomy 13/18/21, microdeletions, expanded aneuploidies), and was GBS+ without concern for PPROM. She had minor symptoms as described in earlier portion of this report soon after the vaccine and an office visit with normal vitals/exam and fetal heart tones less than 24h prior to noting sudden decrease in fetal movement.  She received the RSV vaccine at 36wk 6d and had stillbirth/IUFD at 37wk 5-6d.   The adverse event was stillbirth/IUFD. Unknown if this was related to vaccine but due to no other understood explanation or probable cause for this significant event and the stillbirth occurred within 1wk of administering vaccine,  reporting for potential investigation if pattern were to emerge.
Age: 32.0
Sex: F
Vaccine: RSV
Symptoms: Stillbirth, Uterine contractions during pregnancy
Clinical narrative: 32yo G1P0 with EDD 12/20/23 by LMP consistent with 6w5d u/s.  Pregnancy was complicated by history of infertility due to endometriosis with spontaneous conception, anxiety (no meds), marginal cord insertion.  For marginal cord insertion, she had been followed with growth scans as recently as 11/27/23 which showed  appropriate interval growth (AC 48%ile, EFW 2711g in 25th %ile) and had BPP 8/8 at that time. She had  negative genetics screening by Prequel (neg trisomy 13/18/21, microdeletions, expanded aneuploidies), and was GBS+ without concern for PPROM. She had minor symptoms as described in earlier portion of this report soon after the vaccine and an office visit with normal vitals/exam and fetal heart tones less than 24h prior to noting sudden decrease in fetal movement.  She received the RSV vaccine at 36wk 6d and had stillbirth/IUFD at 37wk 5-6d.   The adverse event was stillbirth/IUFD. Unknown if this was related to vaccine but due to no other understood explanation or probable cause for this significant event and the stillbirth occurred within 1wk of administering vaccine,  reporting for potential investigation if pattern were to emerge.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Cardiac flutter, Cardiac monitoring, Cardiac stress test, Echocardiogram, Electrocardiogram abnormal
Clinical narrative: Fluttering heart on left side of chest noticed about 12 hours after vaccine.  Lasted for about 2 days.  EKG less than 24 hours after vaccine was abnormal and suggested enlargement of left atria.
Age: 49.0
Sex: F
Vaccine: COVID19-2
Symptoms: Left atrial enlargement
Clinical narrative: Fluttering heart on left side of chest noticed about 12 hours after vaccine.  Lasted for about 2 days.  EKG less than 24 hours after vaccine was abnormal and suggested enlargement of left atria.
Age: 9.0
Sex: M
Vaccine: TYP
Symptoms: Headache, Pallor, Peripheral coldness, Syncope
Clinical narrative: pt fained about 3-5 minutes after shot, before fainting, pt was complaining of headaches to his friend and immediately dropped down after.  pt gained conscious back soon. a customer in the store informed me and I ran to pt immediately, he was already awake, pulse normal, looked pale, body temperature seemed warm but hand was cold. Paramedics arrived in about 10 minutes and checked on patient, heart rate seemed normal but recommended him to be checked by a doctor. pt was transported to ER.
Age: 77.0
Sex: M
Vaccine: PNC20
Symptoms: Erythema, Injection site urticaria, Skin warm, Swelling
Clinical narrative: erythema, swelling and heat to touch; started as 2" diameter wheal at injection site; erythema continued to spread and  by 7 days  covered entire lateral aspect of upper arm - went to (minor emergency center) on December 8 and seen by PA - Medrol dose pack prescribed - after 1 day erythema less red, probably resolving
Age: 67.0
Sex: F
Vaccine: FLUA4
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Patient reported to us on December 8, 2023, that about a week following her Fluad 65+ vaccination she began to experience pain and limited use (around 30%) of her right arm. She has seen pain management doctors who related to her that her vaccine could have been administered too high. She reports Googling symptoms and thinks she has SIRVA. She was prescribed meloxicam and has been undergoing physical therapy. She reports now (December 2023) having around 80% use of her arm now. She does not want to take this vaccine again, reporting this is a disturbing event to her since she is a generally active person.
Age: 73.0
Sex: F
Vaccine: COVID19, FLUA4, RSV, VARZOS
Symptoms: Confusional state, Dizziness, Hyperhidrosis, Hypopnoea
Clinical narrative: Shortly after receiving 4 vaccines, the patient started feeling lightheaded. We had patient sit down. She was getting worse and started breathing shallow , started sweating, and became confused. We applied cold compress to the back of patient's heck and gave her water. 911 was contacted. She began to feel better as soon as paramedics arrived. They still wanted her to get checked out and transported her to the hospital.
Age: 64.0
Sex: F
Vaccine: VARZOS
Symptoms: Arthralgia, Injection site warmth, Pain in extremity, Pruritus
Clinical narrative: patient first experienced shoulder ache that eventually involved the full arm. injection site is warm to the touch. patient also itching all over. patient self medicating with diphenhydramine and will contact provider monday morning.
Age: 69.0
Sex: F
Vaccine: RSV
Symptoms: Immediate post-injection reaction, Injected limb mobility decreased, Injection site pain, Pain, Pain in extremity
Clinical narrative: patient called 12/8 and stated that she is still having severe arm pain in the injected arm, she states that the shot was extremely painful on administration and that the pain has not subsided since the vaccination, patient describes pain that including shooting pain to hand and difficulty with movement, patient was advised to follow up with primary health care provider
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site mass, Injection site pain, Injection site reaction, Medical procedure
Clinical narrative: Patient has been experiencing injection site reaction almost 2 weeks after vaccination. Area has gotten lumpy and painful. Pt states that she did a procedure 5 days ago and these symptoms started the day after. This is SPIKEVAX not the original moderna but the option was not listed.
Age: 17.0
Sex: M
Vaccine: FLU4, HPV9
Symptoms: Feeling cold, Hyperhidrosis, Syncope
Clinical narrative: Pt. fainted after receiving both vaccines. He was also sweating and "felt cold".  I told him to lay down for a few minutes. Once feeling better, I had him sit for a few minutes and then stand. No injury occurred. He recovered and was able to walk out of the store. He did not hit his head or have other injury occur.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune disorder, Dermatomyositis
Clinical narrative: I developed the rare auto-immune disorder called Dermatomyositis shortly after receiving this vaccination.
Age: 42.0
Sex: M
Vaccine: COVID19-2
Symptoms: Asthenia, Confusional state, Hot flush
Clinical narrative: Mental confusion, hot flashes, and weakness.  No treatment and symptoms resolved on their own quickly.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: No adverse event
Clinical narrative: NO ADVERSE REACTIONS NOTED
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site irritation, Injection site pruritus, Pruritus, Skin irritation
Clinical narrative: Pt states extremely itchy and irritated all around site of vaccination and neck. She has been taking Benadryl around the clock and states it is not helping.
Age: 64.0
Sex: F
Vaccine: RSV
Symptoms: Cough, Headache, Injection site erythema, Injection site swelling, Respiratory tract congestion
Clinical narrative: Patient experienced headache, chest congestion, runny nose, cough, and swelling/redness at the site of injection.
Age: 64.0
Sex: F
Vaccine: RSV
Symptoms: Rhinorrhoea
Clinical narrative: Patient experienced headache, chest congestion, runny nose, cough, and swelling/redness at the site of injection.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Autoimmune disorder, Oral fungal infection, Pathogen resistance, Pharyngitis, Pyrexia
Clinical narrative: Patient stated that she began experiencing symptoms approximately 4 days after the vaccination. She had repeated fevers and according to her physician has developed an "Autoimmune Disease". She also has reported a resistant fungal infection in her mouth and throat that she is seeking medical treatment from an infectious disease team in the near future.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: 2.5 INCH WIDE, AND 3-INCH-LONG OVAL-SHAPED RED RASH ON THE LEFT ARM precisely around the vaccine injection site
Age: 91.0
Sex: F
Vaccine: VARZOS
Symptoms: Ear swelling, Epistaxis, Injection site swelling
Clinical narrative: Swelling at inj site, swelling of the L ear, nosebleeding that followed, abated after 7 days
Age: 5.0
Sex: F
Vaccine: COVID19
Symptoms: Extra dose administered
Clinical narrative: Patient presented to mass vaccination clinic with parents. Family stated patient had not received a COVID vaccine before, and wanted her to get one today (12/09/23), along with flu shot. Another entity (Clinic) was originally going to give, but did not have COVID vaccine for her age group. Public Health Nurse gave Moderna vaccine to child and Clinic gave flu vaccine to child. After vaccination clinic PHN was entering records into database and noticed child had already received a COVID and flu vaccine this season (approx. two months ago). Health Educator called mother and explained child had already received a dose of both COVID and flu this year and to monitor for any adverse reactions. Described emergency symptoms to watch for and to present to the ER if any develop.
Age: 72.0
Sex: F
Vaccine: COVID19-2
Symptoms: Condition aggravated, Full blood count, Immediate post-injection reaction, Occipital neuralgia, Trigeminal neuralgia
Clinical narrative: trigeminal and occipital neuralgias increased to unbearable pain for about three days. Since then both have remained in elevated state down to about 30% increase than before the vaccine. Over the last two years I've consulted neurologists to try to understand why these pains have been increasing. I've had these pains since head injury in 19752 but never at these levels. I was told originally increase was due to age. I wasn't until this fifth shot that i associate the vaccines with the pain increase. It happened in intense measure and was immediately after the vaccine.
Age: 53.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Headache, Injection site reaction, Local reaction, Myalgia, Neck pain
Clinical narrative: Persistent headache all day the day after I received the vaccines, as well as neck and bilateral arm soreness, and myalgias.  3" x 5" large local reaction in right deltoid at site of Shingrix vaccine. No relief after taking Motrin (500m mg) Dual Action with Tylenol (250 mg) every 8 hours.
Age: 53.0
Sex: F
Vaccine: FLU4, VARZOS
Symptoms: Pain in extremity
Clinical narrative: Persistent headache all day the day after I received the vaccines, as well as neck and bilateral arm soreness, and myalgias.  3" x 5" large local reaction in right deltoid at site of Shingrix vaccine. No relief after taking Motrin (500m mg) Dual Action with Tylenol (250 mg) every 8 hours.